litlas
Log inCreate account

Nicola Normanno

Active 1992–2025

177
Papers
27,245
Citations
77
h-index
161
i10-index

Citations

Citations per year for Nicola Normanno1976: 1 citations1991: 1 citations1993: 1 citations1994: 14 citations1995: 24 citations1996: 17 citations1997: 17 citations1998: 27 citations1999: 28 citations2000: 35 citations2001: 59 citations2002: 75 citations2003: 113 citations2004: 99 citations2005: 147 citations2006: 112 citations2007: 140 citations2008: 133 citations2009: 119 citations2010: 119 citations2011: 117 citations2012: 104 citations2013: 126 citations2014: 125 citations2015: 122 citations2016: 124 citations2017: 156 citations2018: 147 citations2019: 672 citations2020: 748 citations2021: 875 citations2022: 823 citations2023: 805 citations2024: 1,386 citations2025: 741 citations2026: 28 citations1977–1990: no citations, so these years are not shown1992: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,175 citing papers, 17.9% of this breakdownChina: 1,480 citing papers, 12.2% of this breakdownItaly: 1,202 citing papers, 9.9% of this breakdownGermany: 649 citing papers, 5.3% of this breakdownUnited Kingdom: 606 citing papers, 5% of this breakdownFrance: 545 citing papers, 4.5% of this breakdownSpain: 526 citing papers, 4.3% of this breakdownJapan: 424 citing papers, 3.5% of this breakdownNetherlands: 325 citing papers, 2.7% of this breakdownCanada: 311 citing papers, 2.6% of this breakdownIndia: 273 citing papers, 2.2% of this breakdownAustralia: 261 citing papers, 2.1% of this breakdown
0%17.9%Other 27.8%

Institutions

Fields

  • Medicine59.2%
  • Biochemistry, Genetics and Molecular Biology32.7%
  • Immunology and Microbiology1.9%
  • Computer Science1.1%
  • Engineering1%
  • Neuroscience0.9%
  • Other3.2%

Topics

  • Colorectal Cancer Treatments and Studies6.4%
  • Cancer Genomics and Diagnostics6.3%
  • Lung Cancer Treatments and Mutations6%
  • HER2/EGFR in Cancer Research3.7%
  • Genetic factors in colorectal cancer2.9%
  • Cancer Immunotherapy and Biomarkers2.8%
  • Other71.9%

Coauthors

All papers

Open in search
  1. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    Authors: Andrés Cervantes, R. Adam, Susana Roselló, Dirk Arnold, Nicola Normanno, Julien Taı̈eb, Jenny F. Seligmann, Thierry de Baère, Pia Österlund, Takayuki Yoshino, Erika Martinelli - Annals of Oncology 2022 cited by 1,650

  2. ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group

    Authors: Javier Pascual, Gerhardt Attard, François‐Clément Bidard, Giuseppe Curigliano, Leticia De Mattos‐Arruda, Maximilian Diehn, Antoîne Italiano, Johan Lindberg, Jason D. Merker, Clara Montagut, Nicola Normanno, Klaus Pantel, George Pentheroudakis, Sanjay Popat, Jorge S. Reis‐Filho, Jeanne Tie, Joan Seoane, N. Tarazona, Takayuki Yoshino, Nicholas C. Turner - Annals of Oncology 2022 cited by 664

  3. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

    Authors: Eric Van Cutsem, Andrés Cervantes, René Adam, Alberto Sobrero, J. Han van Krieken, Dan Aderka, E. Aranda Aguilar, Alberto Bardelli, Al B. Benson, G. Bodoky, Fortunato Ciardiello, André D’Hoore, Eduardo Díaz‐Rubio, Jean‐Yves Douillard, Michel Ducreux, Alfredo Falcone, Axel Grothey, Thomas Gruenberger, Karin Haustermans, Volker Heinemann, Paulo M. Hoff, C.-H. Köhne, Roberto Labianca, Pierre Laurent‐Puig, Brigette Ma, Tim Maughan, Kei Muro, Nicola Normanno, Pia Österlund, Wim J.G. Oyen, Demetris Papamichael, George Pentheroudakis, Per Pfeiffer, Timothy Price, Cornelis J.A. Punt, Jens Ricke, A. Roth, Ramón Salazar, Werner Scheithauer, Hans‐Joachim Schmoll, Josep Tabernero, Julien Taı̈eb, Sabine Tejpar, Harpreet Wasan, Takayuki Yoshino, Aziz Zaanan, Dirk Arnold - Annals of Oncology 2016 cited by 3,449

  4. Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group

    Authors: Fernanda Mosele, Jordi Remón, Joaquı́n Mateo, C. Benedikt Westphalen, Fabrice Barlési, Martijn P. Lolkema, Nicola Normanno, Aldo Scarpa, Mark E. Robson, Funda Meric‐Bernstam, Nikhil Wagle, Albrecht Stenzinger, Jean-François Bonastre, Ariane Bayle, Stefan Michiels, Ivan Bièche, Étienne Rouleau, S. Jezdic, J.-Y. Douillard, J.S. Reis-Filho, Rodrigo Dienstmann, Fabrice André - Annals of Oncology 2020 cited by 1,188

  5. Delivering precision oncology to patients with cancer

    Authors: Joaquı́n Mateo, Lotte Steuten, Philippe Aftimos, Fabrice André, D. M. Davies, Elena Garralda, Jan Geißler, Don Husereau, Iciar Martinez-Lopez, Nicola Normanno, Jorge S. Reis‐Filho, Stephen Stefani, David M. Thomas, C. Benedikt Westphalen, Emile E. Voest - Nature Medicine 2022 cited by 356

  6. Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group

    Authors: M.F. Mosele, C. Benedikt Westphalen, A Stenzinger, Fabrice Barlési, Ariane Bayle, Ivan Bièche, Jean-François Bonastre, Elena Castro, R. Dienstmann, A. Krämer, Anna M. Czarnecka, Funda Meric‐Bernstam, Stefan Michiels, Rowan Miller, Nicola Normanno, Jorge S. Reis‐Filho, Jordi Remón, Mark E. Robson, E. Rouleau, Aldo Scarpa, C. Serrano, Joaquı́n Mateo, Fabrice André - Annals of Oncology 2024 cited by 345

  7. Epidermal growth factor receptor (EGFR) signaling in cancer

    Authors: Nicola Normanno, Antonella De Luca, Caterina Bianco, Luigi Strizzi, Mario Mancino, Monica R. Maiello, Adele Carotenuto, Gianfranco De Feo, Francesco Caponigro, David Salomon - Gene 2005 cited by 2,019

  8. Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With RAS Wild-type Metastatic Colorectal Cancer

    Authors: Erika Martinelli, Giulia Martini, Vincenzo Famiglietti, Teresa Troiani, Stefania Napolitano, Filippo Pietrantonio, Davide Ciardiello, M. Terminiello, C. Borrelli, Pietro Paolo Vitiello, Filippo de Braud, Federica Morano, Antonio Avallone, Nicola Normanno, Anna Nappi, Evaristo Maiello, Tiziana Pia Latiano, Alfredo Falcone, Chiara Cremolini, Daniele Rossini, Giuseppe Santabarbara, Carmine Pinto, Daniele Santini, Claudia Cardone, N. Zanaletti, Alessandra Di Liello, Daniela Renato, Lucia Esposito, Francesca Marrone, Fortunato Ciardiello - JAMA Oncology 2021 cited by 185

  9. ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer

    Authors: Antonio Passaro, Natasha B. Leighl, Fiona Blackhall, Sanjay Popat, Keith M. Kerr, Myung‐Ju Ahn, Maria E. Arcila, Óscar Arrieta, David Planchard, Filippo de Marinis, Anne‐Marie C. Dingemans, Rafał Dziadziuszko, Corinne Faivre‐Finn, Jill Feldman, Enriqueta Felip, Giuseppe Curigliano, Roy S. Herbst, Pasi A. Jänne, Thomas John, Tetsuya Mitsudomi, Tony Mok, Nicola Normanno, Luis Paz‐Ares, Suresh S. Ramalingam, Lecia V. Sequist, Johan Vansteenkiste, Ignacio I. Wistuba, Juergen Wolf, Yi‐Long Wu, Sihai Yang⧫, James Chih‐Hsin Yang, Yasushi Yatabe, George Pentheroudakis, Solange Peters - Annals of Oncology 2022 cited by 190

  10. The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches

    Authors: Antonella De Luca, Monica R. Maiello, Amelia D’Alessio, Maria Pergameno, Nicola Normanno - Expert Opinion on Therapeutic Targets 2012 cited by 744

  11. European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer

    Authors: Ignace Vergote, Antonio González-Martı́n, Isabelle Ray‐Coquard, Philipp Harter, Nicoletta Colombo, Pascal Pujol, Domenica Lorusso, Mansoor Raza Mirza, Birutė Brasiūnienė, R. Madry, James D. Brenton, Margreet G.E.M. Ausems, Reinhard Büttner, Diether Lambrechts, Ignace Vergote, Margreet G.E.M. Ausems, Birutė Brasiūnienė, James D. Brenton, Reinhard Büttner, Nicoletta Colombo, Antonio González-Martı́n, Philipp Harter, Diether Lambrechts, D. Lorusso, R. Madry, Mansoor Raza Mirza, Pascal Pujol, I. Ray-Coquard, Mauro Henrique Nogueira Guimarães de Abreu, S. Balboni, Susana Banerjee, Massimo Barberis, M.P. Barretina Ginesta, J.F. Baurain, Margherita Bignami, Line Bjørge, Paweł Blecharz, Ilan Bruchim, ME Capilna, Nicoletta Cerana, Americo Cicchetti, Dearbhaile Catherine Collins, Nicole Concin, Maurizio D’Incalci, Brittany A. Davidson, Thibault De La Motte Rouge, Pierandrea De Iaco, Fuat Demirkıran, Hannelore Denys, Thilo Doerk, Anne Dørum, Annamaria Ferrero, Alejandro Perez Fidalgo, Maurizio Genuardi, Laurence Gladieff, Rosalind Glasspool, Christoph Grimm, Murat Gültekin, E. Hahnen, Annette Hasenburg, Alinta Hegmane, Viola Heinzelmann, Estrid Høgdall, Ramūnas Janavičius, Sonata Jarmalaitė, Roshni Kalachand, Radka Kaneva, Saadettin Kılıçkap, Roman Kocián, D. Kolencik, Rebecca Kristeleit, Anna Kryzhanivska, Alexandra Léary, Birthe Lemley, Marjolijn J. L. Ligtenberg, José Antonio López‐Guerrero, Christopher J. Lord, E. Åvall‐Lundqvist, Johanna Mäenpää, Sven Mahner, Frederik Marmé, Christian Marth, Iain A. McNeish, Sabine Merkelbach‐Bruse, Marian J.E. Mourits, Nicola Normanno, Ana Oaknin, Kristiina Ojamaa, C. Papdimitriou, F. Penault-Llorca, Anna Myriam Perrone, Sandro Pignata, Eli Pikarsky, Étienne Rouleau, María Jesús Rubio, Anna Sapino, Barbara Schmalfeldt, Jalid Sehouli, Roni Shapira, Karina Dahl Steffensen and 12 more - Annals of Oncology 2021 cited by 164

  12. Implementing TMB measurement in clinical practice: considerations on assay requirements

    Authors: Reinhard Büttner, John Longshore, Fernando López‐Ríos, Sabine Merkelbach‐Bruse, Nicola Normanno, Etienne Rouleau, Frédérique Penault‐Llorca - ESMO Open 2019 cited by 355

  13. Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives

    Authors: Erika Martinelli, Davide Ciardiello, Giulia Martini, Teresa Troiani, Claudia Cardone, Pietro Paolo Vitiello, Nicola Normanno, Anna Maria Rachiglio, Evaristo Maiello, T. Latiano, Ferdinando De Vita, Fortunato Ciardiello - Annals of Oncology 2020 cited by 224

  14. Point‐of‐Care Testing for the Detection of MicroRNAs: Towards Liquid Biopsy on a Chip

    Authors: G Moro, Chiara Dalle Fratte, Nicola Normanno, Federico Polo, Stefano Cinti - Angewandte Chemie International Edition 2023 cited by 43

  15. VEGF as a potential target in lung cancer

    Authors: Daniela Frezzetti, Marianna Gallo, Monica R. Maiello, Amelia D’Alessio, Claudia Esposito, Nicoletta Chicchinelli, Nicola Normanno, Antonella De Luca - Expert Opinion on Therapeutic Targets 2017 cited by 240

  16. Implementation of precision medicine in healthcare—A European perspective

    Authors: Albrecht Stenzinger, Ejner K. Moltzen, Eva C. Winkler, Fruzsina Molnár‐Gábor, Nisar P. Malek, Alexandru Costescu, Brigitte Nybo Jensen, Frédérique Nowak, Carmine Pinto, Ole Petter Ottersen, Peter Schirmacher, Jenni Nordborg, Thomas Seufferlein, Stefan Fröhling, Anders Edsjö, Jesús García‐Foncillas, Nicola Normanno, Bettina Lundgren, Mikaela Friedman, Natacha Bolaños, Katrina Tatton‐Brown, Sue Hill, Richard Rosenquist - Journal of Internal Medicine 2023 cited by 71

  17. Clinical practice guidelines for BRCA1 and BRCA2 genetic testing

    Authors: Pascal Pujol, Massimo Barberis, Philp Beer, Eitan Friedman, Josep M. Piulats, Ettore Capoluongo, Jesús García‐Foncillas, Isabelle Ray‐Coquard, Frédérique Penault‐Llorca, William D. Foulkes, Clare Turnbull, Helen Hanson, Steven A. Narod, Banu Arun, Matti Aapro, Jean‐Louis Mandel, Nicola Normanno, Diether Lambrechts, Ignace Vergote, Michèle Anahory, Bernard Baertschi, Karen Baudry, Yves–Jean Bignon, Marc A. Bollet, Carole Corsini, Olivier Cussenot, Thibault De La Motte Rouge, Marie Duboys de Labarre, Florence Duchamp, Clarisse Duriez, Karim Fizazi, Virginie Galibert, Laurence Gladieff, Joseph Gligorov, Pascal Hammel, Marion Imbert‐Bouteille, William Jacot, Tatiana Kogut-Kubiak, Pierre‐Jean Lamy, Sophie Nambot, Y. Neuzillet, Sylviane Olschwang, Xavier Rébillard, Jean‐Marc Rey, Chloé Rideau, Jean-Philippe Spano, Frédéric Thomas, Isabelle Treilleux, Marion Vandromme, Julie A. Vendrell, Michèle Vintraud, D. Zarca, Kevin S. Hughes, Jose Enrique Alés Martínez - European Journal of Cancer 2021 cited by 175

  18. KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer

    Authors: Wendy De Roock, Veerle de Vriendt, Nicola Normanno, Fortunato Ciardiello, Sabine Tejpar - The Lancet Oncology 2010 cited by 611

  19. Epidermal growth factor-related peptides and their receptors in human malignancies

    Authors: David S. Salomon, Ralf Brandt, Fortunato Ciardiello, Nicola Normanno - Critical Reviews in Oncology/Hematology 1995 cited by 2,687

  20. ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research

    Authors: Carmen Belli, F. Penault-Llorca, Marc Ladanyi, Nicola Normanno, J.Y. Scoazec, Ludovic Lacroix, Jorge S. Reis‐Filho, Vivek Subbiah, Justin F. Gainor, Volker Endris, Matteo Repetto, Alexander Drilon, Aldo Scarpa, Fabrice André, J.-Y. Douillard, Giuseppe Curigliano - Annals of Oncology 2021 cited by 121

  21. Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC: The BEVERLY Multicenter Randomized Phase 3 Trial

    Authors: Maria Carmela Piccirillo, Laura Bonanno, Marina Chiara Garassino, Giovanna Esposito, Claudio Dazzi, Luigi Cavanna, Marco Angelo Burgio, Francesco Rosetti, Simona Rizzato, Floriana Morgillo, Saverio Cinieri, Antonello Veccia, Maximilan Papi, Giuseppe Tonini, Vittorio Gebbia, Serena Ricciardi, Daniele Pozzessere, Alessandra Ferro, Claudia Proto, Raffaele Costanzo, M. D’Arcangelo, Manuela Proietto, Piera Gargiulo, Raimondo Di Liello, Laura Arenare, Filippo de Marinis, Lucio Crinò, Fortunato Ciardiello, Nicola Normanno, Ciro Gallo, Francesco Perrone, Cesare Gridelli, Alessandro Morabito - Journal of Thoracic Oncology 2022 cited by 68

  22. Access and quality of biomarker testing for precision oncology in Europe

    Authors: Nicola Normanno, Kathi Apostolidis, Audrey B. Wolf, Raed Al Dieri, Zandra C. Deans, Jenni Fairley, J. Maas, Antonio Martı́nez, Holger Moch, Søren Nielsen, Thomas Pilz, Etienne Rouleau, Simon Patton, Victoria Williams - European Journal of Cancer 2022 cited by 82

  23. Practical considerations in screening for genetic alterations in cholangiocarcinoma

    Authors: Tanios Bekaii‐Saab, John Bridgewater, Nicola Normanno - Annals of Oncology 2021 cited by 137

  24. In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies

    Authors: Caterina Ieranò, Dario Righelli, Crescenzo D’Alterio, Maria Napolitano, Luigi Portella, Giuseppina Rea, Federica Auletta, Sara Santagata, Anna Maria Trotta, Giuseppe Guardascione, Federica Liotti, Nella Prevete, Piera Maiolino, Antonio Luciano, Antônio Barbieri, Annabella Di Mauro, Cristin Roma, Riziero Esposito Abate, Fabiana Tatangelo, Roberto Pacelli, Nicola Normanno, Rosa Marina Melillo, Stefania Scala - Journal for ImmunoTherapy of Cancer 2022 cited by 64